Proteros will additionally provide Gene-to-Structure services.
Proteros biostructures and OSI Pharmaceuticals have expanded their protein crystallography partnership for the fifth time. Proteros will now also provide Gene-to-Structure services.
The extension follows the successful delivery of high-resolution protein-ligand structures on multiple kinase targets under Proteros’ Gallery Structure mode with compounds supplied by OSI, the company’s report.
The master service agreement, signed in October 2007, calls for Proteros to utilize its capabilities in construct design, protein expression and purification, as well as protein-structure determination to deliver a de novo protein structure and protein-ligand structures on a challenging kinase target.
